These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3783804)

  • 1. Pharmacokinetics of oral and intravenous bromide in normal volunteers.
    Vaiseman N; Koren G; Pencharz P
    J Toxicol Clin Toxicol; 1986; 24(5):403-13. PubMed ID: 3783804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of oral and intravenous administration of sodium bromide for extracellular water measurements.
    Vaisman N; Pencharz PB; Koren G; Johnson JK
    Am J Clin Nutr; 1987 Jul; 46(1):1-4. PubMed ID: 3604959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of bromide in adult sheep following oral and intravenous administration.
    Quast TA; Combs MD; Edwards SH
    Aust Vet J; 2015; 93(1-2):20-5. PubMed ID: 25622704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and clinical utility of sodium bromide (NaBr) as an estimator of extracellular fluid volume in horses.
    Fielding CL; Magdesian KG; Elliott DA; Craigmill AL; Wilson WD; Carlson GP
    J Vet Intern Med; 2003; 17(2):213-7. PubMed ID: 12683623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromide pharmacokinetics in cystic fibrosis.
    Miller ME; Kornhauser DM
    Arch Pediatr Adolesc Med; 1994 Mar; 148(3):266-71. PubMed ID: 8130858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimum doses of deuterium oxide and sodium bromide for the determination of total body water and extracellular fluid.
    Thomas LD; Vander Velde D; Schloerb PR
    J Pharm Biomed Anal; 1991; 9(7):581-4. PubMed ID: 1667897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of diltiazem after intravenous and oral administration.
    Hermann P; Rodger SD; Remones G; Thenot JP; London DR; Morselli PL
    Eur J Clin Pharmacol; 1983; 24(3):349-52. PubMed ID: 6861848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and toxicity of bromide following high-dose oral potassium bromide administration in healthy Beagles.
    March PA; Podell M; Sams RA
    J Vet Pharmacol Ther; 2002 Dec; 25(6):425-32. PubMed ID: 12485348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic bromide intoxication caused by bromide-containing combination drugs].
    Steinhoff BJ; Paulus W
    Dtsch Med Wochenschr; 1992 Jul; 117(27):1061-4. PubMed ID: 1618120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of bromide by the canine prostate.
    Smith ER; Ilievski V
    Prostate; 1985; 6(2):155-62. PubMed ID: 3975176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function.
    Aronoff G; Brier M; Mayer ML; Barbalas M; Aogaichi K; Sloan R; Brazzell R; Massarella J
    J Clin Pharmacol; 1991 Jan; 31(1):38-44. PubMed ID: 2045527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers.
    Tangphao O; Grossmann M; Chalon S; Hoffman BB; Blaschke TF
    Br J Clin Pharmacol; 1999 Mar; 47(3):261-6. PubMed ID: 10215749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of sodium bromide in man: a study in human volunteers with special emphasis on the endocrine and the central nervous system.
    Sangster B; Blom JL; Sekhuis VM; Loeber JG; Rauws AG; Koedam JC; Krajnc EI; van Logten MJ
    Food Chem Toxicol; 1983 Aug; 21(4):409-19. PubMed ID: 6684622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
    Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
    Jansat JM; Costa J; Salvà P; Fernandez FJ; Martinez-Tobed A
    J Clin Pharmacol; 2002 Dec; 42(12):1303-10. PubMed ID: 12463724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyceryl-1-nitrate pharmacokinetics in healthy volunteers.
    Laufen H; Leitold M
    Br J Clin Pharmacol; 1987 Mar; 23(3):287-93. PubMed ID: 3105569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single- and multiple-dose mibefradil pharmacokinetics in normal and hypertensive subjects.
    Welker HA
    J Pharm Pharmacol; 1998 Sep; 50(9):983-7. PubMed ID: 9811158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.